Long-Term Versus Short-Term Treatment With Recombinant Interferon Alfa-2a in Patients With Chronic Hepatitis B: A Prospective, Randomized Treatment Trial
- 1 October 1990
- journal article
- research article
- Published by Elsevier in Mayo Clinic Proceedings
- Vol. 65 (10) , 1330-1335
- https://doi.org/10.1016/s0025-6196(12)62144-2
Abstract
No abstract availableThis publication has 5 references indexed in Scilit:
- A Randomized, Controlled Trial of Interferon Alfa-2b Alone and after Prednisone Withdrawal for the Treatment of Chronic Hepatitis BNew England Journal of Medicine, 1990
- Hepatitis B virus deoxyribonucleic acid in serum during hepatitis B e antigen clearance in corticosteroid-treated severe chronic active hepatitis BGastroenterology, 1987
- LOSS OF HBsAg WITH INTERFERON THERAPY IN CHRONIC HEPATITIS B VIRUS INFECTIONThe Lancet, 1987
- Lymphoblastoid interferon therapy of chronic HBV infectionJournal of Hepatology, 1987
- ANTIVIRAL THERAPY IN HEPATITIS B INFECTIONBritish Medical Bulletin, 1985